Greater than eight in ten of customers of GLP-1 medicine within the US skilled “main modifications” of their meals and beverage preferences after beginning the treatment, a brand new research has claimed.
The analysis, printed by elements provider IFF, claimed GLP-1 medicine, marketed beneath manufacturers together with Wegovy and Ozempic, “alter style notion” and “disrupt the notion of sweetness, bitterness, fatty meals and even mouthfeel”.
The modifications are significantly pronounced within the early phases of remedy, the research mentioned.
Meals beforehand thought of pleasing develop into “off-putting or insupportable”, the IFF report famous.
In response to the analysis, “among the many most incessantly rejected” merchandise are fatty dishes, deli meats, sweets, espresso and alcohol. Customers “gravitate” towards choices akin to fruits, lean proteins and plant-based merchandise.
Textural preferences are additionally affected, with “dry mouth and digestive unwanted effects” main many to keep away from dry, sticky or overly dense meals, the report mentioned.
IFF mentioned it had analysed public discussions on social media and located style ranked among the many prime 5 considerations for GLP-1 customers primarily based within the US.
A research by Cornell College and consumer-insights group Numerator printed earlier this yr claimed that GLP-1 drug customers within the US lower their grocery spending by a median of 5.5% within the six months after taking the treatment.
There was a 2.4% enhance in spending on yogurt amongst “GLP-1 households”, the analysis confirmed. Gross sales of meat snacks grew 1%.
Nonetheless, cheese gross sales declined 7.2% and spending on crisps and savoury snacks fell greater than 11%.
Spending on drinks decreased throughout the board. Mushy drinks noticed a 6.6% drop, adopted by a 3.7% decline within the mixed spending on espresso, tea and vitality drinks. Spending on alcohol dropped by 1.4%.
IFF mentioned meals and drinks producers wanted to evaluate how they develop merchandise to satisfy the wants of the customers of GLP-1 medicine.
The US-based group mentioned product builders ought to “steadiness dietary worth with sensory enchantment”, deal with “acquainted and purposeful” flavours, incorporate hydration into the merchandise, prioritise what it referred to as “digestive consolation” and provide “satisfying parts in compact codecs”.
The elevated use of GLP-1 medicine has sparked concern in regards to the potential affect on the revenues of packaged-food producers.
Nestlé has launched a pre-meal drink beneath its Enhance model aimed toward GLP-1 drug customers within the US. The Swiss large can also be promoting a variety of meals within the US designed as a “companion” for these taking GLP-1 weight-loss treatment.
Conagra Manufacturers can also be placing labels on a few of its Wholesome Selection merchandise in a bid to catch the attention of customers of GLP-1 medicine.
Join our every day information round-up!
Give your corporation an edge with our main business insights.
Greater than eight in ten of customers of GLP-1 medicine within the US skilled “main modifications” of their meals and beverage preferences after beginning the treatment, a brand new research has claimed.
The analysis, printed by elements provider IFF, claimed GLP-1 medicine, marketed beneath manufacturers together with Wegovy and Ozempic, “alter style notion” and “disrupt the notion of sweetness, bitterness, fatty meals and even mouthfeel”.
The modifications are significantly pronounced within the early phases of remedy, the research mentioned.
Meals beforehand thought of pleasing develop into “off-putting or insupportable”, the IFF report famous.
In response to the analysis, “among the many most incessantly rejected” merchandise are fatty dishes, deli meats, sweets, espresso and alcohol. Customers “gravitate” towards choices akin to fruits, lean proteins and plant-based merchandise.
Textural preferences are additionally affected, with “dry mouth and digestive unwanted effects” main many to keep away from dry, sticky or overly dense meals, the report mentioned.
IFF mentioned it had analysed public discussions on social media and located style ranked among the many prime 5 considerations for GLP-1 customers primarily based within the US.
A research by Cornell College and consumer-insights group Numerator printed earlier this yr claimed that GLP-1 drug customers within the US lower their grocery spending by a median of 5.5% within the six months after taking the treatment.
There was a 2.4% enhance in spending on yogurt amongst “GLP-1 households”, the analysis confirmed. Gross sales of meat snacks grew 1%.
Nonetheless, cheese gross sales declined 7.2% and spending on crisps and savoury snacks fell greater than 11%.
Spending on drinks decreased throughout the board. Mushy drinks noticed a 6.6% drop, adopted by a 3.7% decline within the mixed spending on espresso, tea and vitality drinks. Spending on alcohol dropped by 1.4%.
IFF mentioned meals and drinks producers wanted to evaluate how they develop merchandise to satisfy the wants of the customers of GLP-1 medicine.
The US-based group mentioned product builders ought to “steadiness dietary worth with sensory enchantment”, deal with “acquainted and purposeful” flavours, incorporate hydration into the merchandise, prioritise what it referred to as “digestive consolation” and provide “satisfying parts in compact codecs”.
The elevated use of GLP-1 medicine has sparked concern in regards to the potential affect on the revenues of packaged-food producers.
Nestlé has launched a pre-meal drink beneath its Enhance model aimed toward GLP-1 drug customers within the US. The Swiss large can also be promoting a variety of meals within the US designed as a “companion” for these taking GLP-1 weight-loss treatment.
Conagra Manufacturers can also be placing labels on a few of its Wholesome Selection merchandise in a bid to catch the attention of customers of GLP-1 medicine.
